Personalizing evidence-based primary prevention with aspirin: individualized risks and patient preference.
作者信息
Kent David M, Shah Nilay D
出版信息
Circ Cardiovasc Qual Outcomes. 2011 May;4(3):260-2. doi: 10.1161/CIRCOUTCOMES.111.961136.
Abstract
摘要
相似文献
1
Personalizing evidence-based primary prevention with aspirin: individualized risks and patient preference.
Circ Cardiovasc Qual Outcomes. 2011 May;4(3):260-2. doi: 10.1161/CIRCOUTCOMES.111.961136.
2
Aspirin for primary prevention: a challenging decision.
J Am Heart Assoc. 2014 Aug 21;3(4):e001254. doi: 10.1161/JAHA.114.001254.
3
The case against routine aspirin use for primary prevention in low-risk adults.
Am Fam Physician. 2011 Jun 15;83(12):1387-90.
4
Aspirin for the primary prevention of cardiovascular events: recommendations and rationale.
Am J Nurs. 2002 Mar;102(3):67, 69-70.
5
Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular events.
Am J Med. 2004 Oct 1;117(7):528-30. doi: 10.1016/j.amjmed.2004.07.037.
6
Appropriate aspirin use for primary prevention of cardiovascular disease.
Am Fam Physician. 2011 Jun 15;83(12):1380-6.
7
Aspirin for the primary prevention of cardiovascular diseases.
Intern Emerg Med. 2012 Aug;7(4):375-9. doi: 10.1007/s11739-012-0791-z. Epub 2012 Jun 6.
8
Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
Am J Med. 2004 Oct 1;117(7):459-68. doi: 10.1016/j.amjmed.2004.04.017.
9
Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.
J Vasc Nurs. 2010 Dec;28(4):154-5. doi: 10.1016/j.jvn.2010.10.002.
10
Responses to USPSTF guideline on aspirin for prevention of cardiovascular disease.
Ann Intern Med. 2009 Oct 20;151(8):587-8; author reply 588. doi: 10.7326/0003-4819-151-8-200910200-00018.
引用本文的文献
1
Patient-Centered Decision Support: Formative Usability Evaluation of Integrated Clinical Decision Support With a Patient Decision Aid for Minor Head Injury in the Emergency Department.
J Med Internet Res. 2017 May 19;19(5):e174. doi: 10.2196/jmir.7846.
2
Shared decision making in patients with stable coronary artery disease: PCI choice.
PLoS One. 2012;7(11):e49827. doi: 10.1371/journal.pone.0049827. Epub 2012 Nov 30.
3
Acetylsalicylic acid/esomeprazole fixed-dose combination.
Drugs Aging. 2012 Mar 1;29(3):233-242. doi: 10.2165/11208610-000000000-00000.
本文引用的文献
1
Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized trial.
Am J Med. 2011 Jun;124(6):549-56. doi: 10.1016/j.amjmed.2011.01.013.
2
Individual and population benefits of daily aspirin therapy: a proposal for personalizing national guidelines.
Circ Cardiovasc Qual Outcomes. 2011 May;4(3):268-75. doi: 10.1161/CIRCOUTCOMES.110.959239. Epub 2011 Apr 12.
3
Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease.
Ann Intern Med. 2010 Sep 7;153(5):307-13. doi: 10.7326/0003-4819-153-5-201009070-00005.
4
The diabetes mellitus medication choice decision aid: a randomized trial.
Arch Intern Med. 2009 Sep 28;169(17):1560-8. doi: 10.1001/archinternmed.2009.293.
5
The effect of alternative summary statistics for communicating risk reduction on decisions about taking statins: a randomized trial.
PLoS Med. 2009 Aug;6(8):e1000134. doi: 10.1371/journal.pmed.1000134. Epub 2009 Aug 25.
6
Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med. 2009 Mar 17;150(6):396-404. doi: 10.7326/0003-4819-150-6-200903170-00008.
7
Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis.
Lancet. 2009 Mar 14;373(9667):911-8. doi: 10.1016/S0140-6736(09)60319-6.
8
A treatment decision aid may increase patient trust in the diabetes specialist. The Statin Choice randomized trial.
Health Expect. 2009 Mar;12(1):38-44. doi: 10.1111/j.1369-7625.2008.00521.x.
9
How do patients perceive the benefits and risks of peripheral angioplasty? Implications for informed consent.
J Vasc Interv Radiol. 2008 Feb;19(2 Pt 1):177-81. doi: 10.1016/j.jvir.2007.10.016.
10
Patient perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel disease.
Inflamm Bowel Dis. 2008 Jan;14(1):1-6. doi: 10.1002/ibd.20283.
Zotero 插件